CEO Patrick Spearman said he expects the FDA to grant Envoy’s Premarket Approval (PMA) application by next February. Although FDA advisory panel recommendations are not binding, the agency almost always follows them.
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.